Anonymous
Guest
Anonymous
Guest
Any information about EPIFIX®??
“The U.S. launch of EPIFIX® by Systagenix will strengthen our leadership position in the advanced wound care therapies segment, building on our success with PROMOGRAN® and PROMOGRAN PRISMA®. With no need for cold supply chain, a 5-year shelf life and outstanding clinical performance, we believe this tissue will offer a much improved proposition for those clinicians that use these types of grafts on a regular basis” said Joel Pickering, General Manager, Systagenix U.S.
“The U.S. launch of EPIFIX® by Systagenix will strengthen our leadership position in the advanced wound care therapies segment, building on our success with PROMOGRAN® and PROMOGRAN PRISMA®. With no need for cold supply chain, a 5-year shelf life and outstanding clinical performance, we believe this tissue will offer a much improved proposition for those clinicians that use these types of grafts on a regular basis” said Joel Pickering, General Manager, Systagenix U.S.